With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|MicroRNAs 100 and 125b in Ewing sarcoma||University of Colorado Denver / Paul Jedlicka||Young Investigator Grants||2010||Colorado|
|Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture||Children's Hospital Los Angeles / Theresa Harned, MD||Young Investigator Grants||2006||California|
|Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.||Massachusetts General Hospital / David Langenau||Young Investigator Grants||2009||Massachusetts|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.||Columbia University / Teresa Palomero, PhD||Young Investigator Grants||2007||New York|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model||University of California San Francisco / Jean Nakamura||Young Investigator Grants||2011||California|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor||Dana-Farber Cancer Institute / Shuning He, PhD||Young Investigator Grants||2015||Massachusetts|
|A mouse model of Wilms' Tumor||Massachusetts General Hospital / Nabeel Bardeesy, PhD||Young Investigator Grants||2008||Massachusetts|